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DEVELOPMENT OF A PROTOTYPE SPACE FLIGHT 
INTRAVENOUS INJECTION SYSTEM 
1.0 INTRODUCTION 
Medical emergencies, especially those resulting from accidents, 
frequently require the administration of intravenous fluids to 
replace lost body liquid. A system to provide this capability in 
space 1.s required. Existing systems do not meet space flight 
requirements. 
2.0 BACKGROUND 
Storage and weight limitations on space vehicles preclude the 
inclusion of large quantities and varieties of injectables or 
infusables. In addition, the handling and transfer of fluids 
under conditions of micro gravity further impact an intravenous 
injection system. 
The weight and volume of an injection system can be reduced 
significantly by providing the injectables in a concentrated 
form. These can then be reconstituted prior to being 
administered through the addition of water. System weight and 
volume can be further reduced by utilizing water from the 
spacecraft potable water system. As long as the water in the 
potable system meets the potability requirements, it will meet 
most of the requirements for injection as outlined in the U. S. 
Pharmacopoeia. However, aseptic transfer from the potable system 
cannot be guaranteed with present equipment, consequently 
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provision must be made to prevent the inclusion of 
microorganisms, (or other contaminants), during attachment of the 
reconstitution hardware to the water dispenser. In addition, 
in an emergency situation, the chemical quality of the water may 
be questionable. 
The administration of fluids in the absence of gravity requires a 
positive feed system which can be controlled and monitored. Due 
to the anticipated infrequency of need, a system which has no 
vehicle interfaces such as pneumatic and electical, and has a 
long unattended shelf life is desireable. 
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3.0 TECHNICAL APPROACH 
The development of a prototype space flight intravenous injection 
system was accomplished by six tasks: The definition of 
requirements, injectable concentrates development, water 
polisher, reconstitution hardware development, administration 
hardware development, and prototype fabrication and test. 
3.1 Definition of Requirements. 
The basic requirements for the system were defined at a meeting 
at JSC in May of 1981. At this time the basic proposed system 
approach was presented and JSC medical and engineering personnel 
made appropriate decisions regarding the requirements. 
It was agreed that the goal of the program was to provide the 
capability to provide emergency IV therapy to a Shuttle crew 
member for a period long enough to permit return to the ground. 
The assumption was that any injury or illness serious enough to 
require IV therapy would result in a mission abort within one or 
two days. Consequently, the administration hardware could be 
designed for single use. 
The initially proposed hardware approach (circa March 1983) is 
shown in Figure 3-1. Potable water from a dispenser is passed 
through a purifier and fills a bag containing a glass ampule 
containing dehydrated solute, which is broken before the filling 
process is started. 
Administration will be accomplished by pressurizing the bag and 
controlling the flow with adjustable restrictions. 
After presentation of the proposed approach and deliberation, the 
major conclusions of the meeting were: 
a. Solutions must meet requirements of the USP Reference 1. 
b. Standardize on a 1 liter capacity system. 
c. Provide ports on both the bags and IV tubing to permit 
the addition of medication. 
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d. Two solutions will be provided, Normal Saline and 
Lactated Ringers. 
e. A strong objection was made to the breaking of glass 
ampules inside the system. This presented a design 
problem with isolating the various zones of the 
purification system. 
f. Flow rate capabilities shall range from the maximum 
possible to TKO (To Keep Open, lcc/hr). Normal 
maintenance flows should be around 100 to 150 cc/hr. 
g. Shelf Life 1 year minimum. 
I 
Based on the above design requirements, the following development 
programs were initiated. 
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4.0 INJECTABLE CONCENTRATES DEVELOPMENT 
I .  
During the Definition of Requirements, two injectable solutions 
were specified, Normal Saline and Lactated Ringers. The USP 
specifications and tolerances for the solutes in these 
injectables are shown in Table 4-1. 
I 
I 
Normal Saline for Injection contains 0.9% Sodium Chloride. Salt 
is readily soluble at this level and could be used either as the 
USP powder, or a concentrated solution in the IV bag. One 
reservation on using the powder is the possible inclusion of 
insoluble particulates. 
Another potential problem with using a dry powder is the 
absorption of small amounts of moisture through the bag which 
would result in cakeing of the salt. This makes dissolution more 
difficult, and complete solubilization and mixing questionable in 
a reasonable amount of time. 
Lactated Ringers is a solution of calcium chloride, potassium 
chloride, sodium chloride, and sodium lactate. Sodium lactate is 
a hygroscopic liquid at room temperature, and is purchased as a 
60% solution. This solution contains no preservative, but the 
osmotic pressure is apparently very high, since an aerobic plate 
count taken on a sample from the reagent bottle showed less 
than 10 organisms/ml. A readily soluble slurry was prepared 
from pure sodium lactate and the other salts. Enough slurry to 
make 1 liter of Lactated Ringers was easily dissolved in 30 ml 
of water. Thus the concentrate can be introducted into the bag 
either as the slurry or the 30 ml concentrated solution. 
In light of the possible dissolution problems with salt, and the 
fact that sodium lactate is a liquid, it was decided that both 
solutes would be best provided in the form of a concentrated 
liquid. Each can be provided as a stable solution of 30 ml for a 
one liter final solution. 
All solute concentrations are prepared from USP grade reagents. 
The sodium chloride and potassium chloride are heated at 180 
degrees centigrade for 1 hour to destroy any possible pyrogen 
contamination, (these comprise the bulk of both concentrates) , 
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TABLE 4-1. USP SOLUTE REQUIREMENTS FOR 
IN JECTABLES 
Sodium 
Potassium 
Calcium 
Chloride 
Lactate 
Sodium 
Chloride 
Lactated Ringers for Injection 
mg/liter 
2850 - 3150 
141 - 173 
49 - 60 
3680 - 4080 
2310 - 2610 
Saline for Injection 
mg / 1 iter 
3364 - 3719 
5187 - 5733 
I 
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I 
the liquid sodium lactate can not be heated since it decomposes 
at 140 degrees centigrade, and the calcium chloride dehydrates 
unpredictably, making weighing difficult. 
The concentrates are prepared by'weighing the solutes in pyrogen 
free glassware and dissolving in pyrogen free water. After 
autoclaving, the solutions are analyzed for each constituent as 
specified in the USP. Adjustments are made as necessary to 
provide the proper balance in the individual constituents. An 
aliquot is then diluted to the final concentration and tested for 
Samples of both concentrates were innoculated with 100/ml of 
a mixture of wild bacteria and incubated for 48 hours at 35 
degrees centigrade. Aerobic plate counts after incubation showed 
no growth, indicating that the concentrates are at least 
bacteriastatic due to their high solute concentrations. However, 
it is proposed that.the concentrates be sterilized insitu to the 
containers after they are packaged. 
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5.0 RECONSTITUTION HARDWARE 
The original design concept involved storing the solute 
concentrates in glass ampules inside the IV bags, which would be 
broken for reconstitution. This concept was abandoned, and the 
inclusion of the concentrate within the bag with no other 
container was considered. This approach is not feasable since 
the bag materials will not withstand autoclaving, and the 
sterilization of solutions with ethylene oxide (the process used 
for bags and other dry equipment), is not practical. Gamma 
irradiation is a possible approach to this problem. In 
addition, if the concentrate is included in the "bag" a complete 
IV bag set would be required for each liter of solution. 
Another approach that was considered is the storage of the 
concentrates in syringes, which would be injected into the bags 
before filling. This approach was rejected due to the difficulty 
in hermetically sealing the filled syringes, and the possibility 
of the crewmember forgetting to add concentrate before filling 
the bag, and infusing the patient with water. 
The adopted approach is the flow-thru pouch shown in Figure 5-1. 
The pouch is fabricated from pharmacutical grade 
polyvinylchloride tubing. The end fittings are female luer locks 
with a membrane incorporated below the end of the tapered 
section. The pouches are sterilized by ethylene oxide and filled 
using aseptic techniques with a measured volume of concentrate. 
Pyrogen free water is then added to displace all the air up into 
the fill tube. A portion of the fill tube is wetted with 
methylcyclohexanone (the solvent used to assemble all IV and 
blood collecting equipment), and clamped overnight to make 
permanently fused joints. The entire filling process is carried 
out in a laminar flow bench under irradiation by ultra violet 
lamps. The filled pouches may be pastuerized to destroy any 
bacteria included during the filling process, or irradiated with 
gamma rays. 
The concentrate pouches are used to connect the IV bags to the 
water purifier when being filled. The bag fill tubes and the 
purifier cartridges have 15 gage needles mounted in male luer 
lock fittings which puncture the pouch membranes when connected 
for filling. This fitting arrangement insures that each bag is 
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filled through a concentrate pouch, and prevents the accidental 
filling of a bag with water without concentrate since it is 
physically impossible to directly connect the polishers to the 
bag. 
A series of tests were conducted to evaluate the reliability of 
the filling process, and the efficiency of flushing the 
concentrate from the pouch into the bag. The results of tests on 
ten pouches are shown in Table 5-1. The first five tests were 
conducted with the pouches horizontal, the closest simulation of 
microgravity operation. The last five were conducted with the 
pouch on a vertical position, some with flow from the top to 
bottom, and bottom to top which is the worst case in terms of 
density stratification. In all cases, the resulting solution, 
after mixing was well within the plus or minus 5% tolerances 
specified by the USP. 
Additional testing showed solutions prepared from pouches to be 
sterile and pyrogen free. 
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TEST 
TABLE 5-1. RECONSTITUTION TEST RESULTS. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Limit 
ORIENTATION 
horizontal 
11 II 
I1 I t  
vertical 
I1 
11 
FLOW 
horizontal 
11 I1 
I1 I1 
11 It  
UP 
I1 
down 
DEVIATION % 
2 . 1  
3 . 7  
0 . 4  
-0.2 
1.8 
-1.2 
-1.8 
-2.8 
1.1 
-1.5 
k 5 . 0  
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6.0 Water Polisher Development 
The goal of this task was to develop a device that will guarantee 
that the water used to reconstitute the concentrate results in IV 
solutions that meet all USP criteria. The potability 
requirements for Shuttle water are shown in Table 6-1. With the 
exception of copper and zinc, which are not used or have ever 
been detected in the Shuttle water system, all parameters meet 
or exceed those of the USP for injectable water. The three types 
of possible contaminants that must be addressed to guarantee USP 
suitability are microbiological, inorganic chemicals (primarily 
heavy metals), and organic chemicals (most importantly, 
pyrogens). Microbiological contamination will be prevented by 
iodination, inorganics removed with ion exchange resins and 
organics by activated carbon. 
The basic configuration of the device to be used as a polisher, 
or purifier, is shown in Figure 6-1. Potable water is supplied 
from the drinking water dispenser via a hose fitting with a 
needle mounted in a locking fitting. The needle punctures the 
first membrane of a sealed cartridge containing iodinated resin. 
This resin produces 2 ppm of Iodine and is the active biocide used in 
the Microbial Check Valve in the Shuttle water system. A summary 
of the successful challenges of this resin is shown in Table 6-2. 
This resin is maintained in a sealed cartridge to prevent the 
migration of elemental iodine from the resin into the remainder 
of the purifier at the other end during storage. The second 
membrane is punctured to permit flow by pushing the two sections 
together. 
The water then passes through the anion exchange resin and a 
cation exchange resin where inorganic chemicals are removed. The 
activated charcoal removes any organic contaminants which may be 
in the feed water in addition to materials which may bleed from 
the ion exchange resins. 
6.1 Contaminant Control Beds 
The goal of this task was to develop a device to produce water 
which meets all the requirements of USP for Sodium Chloride for 
Injection and Lactated Ringers for Injection. The primary 
requirements listed in the USP citations for each solution 
Table 6 - 1 , Space Shut t le  Potable Water Requirements 
Ref. SD-W-0020 
Proper t i es 
a .  pH 
b.  Total Sol ids  
c. Taste and Odor 
d .  Turbidity 
e. Color, True 
f .  Total  Organics 
P a r t i c u l a t e  S ize  Range 
a.  0-10 microns 
b. 10-25 microns 
c. 25-50 microns 
d .  50-100 microns . 
e. 100-250 microns 
Ionic Species 
a .  A1umir;um 
b .  Cadmium 
c.  Chloride 
d .  Chromium 
e. Copper 
f .  Iron 
g. lead 
h. Magnesium 
i .  Manganese 
j .  Mercury 
k .  Nickel 
1.  Potassium 
m. Selenium 
n .  S i l i c a  
0. S i l v e r  
p.  Ammonia 
q. Zinc 
(Hexavalent) 
L i m i .  t s  (Maximum 41 lowance) 
5.0-8 a t  25 degrees C ( 7 7  F )  
20 pp!n 
Nofie a t  Threshold (Odor  No. of 3 )  
11 Units 
35 Units 
10 ppm 
No. of Par t ic les  per 500 m? Fluid 
Unl imi ted 
1000 
200 
100 
10 
Maximum Allowable Concentration 
For reference only 
0.01 ppm 
1 . 0  ppm 
0.05 ppm 
1.0 ppm 
0.3 pprn 
0.05 ppm 
For reference only 
0.05 ppm 
0.005 ppm 
0.05 pprn 
For reference only  
0.05 ppm 
For reference only 
0.05 ppm 
0.5 ppm 
5.0 ppm 
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TABLE 6-2. MICROBIAL CHECK VALVE CHALLENGES 
SUSPENSIONS 
1. 
2. 
3 .  
4 .  
5. 
6. 
7. 
8 .  
Escherichia coli 
Streptococcus faecalis 
Staphylococcus aureus 
Bacillus subtilis 
Pseudomonas aeruginosa 
Clostridium perfringens 
Aspergillus niger 
Mixture of all the above 
organisms 
No. of Organisms 
Per Milliliter 
10 
lo6 
lo6 
lo6 
10 
lo6 
lo6 
104 
Complete deactivation of a l l  organisms in effluent. 
9. Reovirus 
10. Adenovirus 
Instantaneous deactivation of TCDs0>104 
11. Type 1 Polio Complete deactivation after 15 min of 
TCD50>104 
involve the concentration limits for the various solutes. In 
addition each references the requirements for Sterile Water for 
Injection which has a few specific requirements, and it in turn 
references the requirements for Purified Water. This sequential 
referencing, in some cases, results in requirements which are of 
questionable importance, as will be discussed later. The various 
requirements are presented in Table 6-3, as well as the results 
of test results from challenges to verify the ability of system 
components to remove potential contaminants. One liter' of water 
containing approximately ten times the USP limit or ten times the 
drinking water limit was passed through a 4 cubic centimeter bed 
of cation and anion exchange resin, previously sieved to 30 to 40 
mesh. (Preliminary tests with resin in the form supplied by the 
manufacturer, 16 to 50 mesh showed unreliable results.) The 
resulting effluent was then tested for removal efficiency. A 
discussion of the individual test results follows: 
Water Parameters and Test Results 
pH - The water produced by the ion exchasnge columns will 
have essentially no ions, consequently the purity of the salts 
used to produce the solutions will have the major effect on the 
resulting pH. 
C1 - The tolerances of both solutions are in the 
neighborhood of 4 grams/liter. It is inconceivable that water 
containing enough chloride to produce a solution that would not 
meet the specification would ever be encountered. 
SO4 - The Purified Water test is sensitive at a level of 
approximately 5 mg/liter. The anion bed reduced an 11 mg/liter 
solution to 3 mg/liter. 
"3 - The cation bed reduced a 2.4 ppm solution to less 
than 0.01 ppm. 
Ca - The Purified Water test is sensitive to 
approximately 5 ppm Ca. The cation bed reduced a 49 ppm solution 
to less than 4 ppm. 
C02 - The Purified Water test is sensitive to 
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I 
approximately 60 mg/liter. This is approximately equivalent to 
the theoretical capacity of a 4 cc bed. It does not appear to be 
realistic to use a bed large enough to handle ten times this 
limit. Medical advice indicates that the effect of high C02 or 
carbonate levels is of little concern, and a failure mode of the 
potable water system that would produce high C02 levels in the 
water is not immediately obvious. There is no known source of ' 
C02 in this water system. 
As - The limit for arsenic is 0.08 ppm. A mixed bed 
reduced 0.8 ppm to 0.07 ppm. 
Fe - The total iron limit is 2 ppm. The cation bed 
reduced a 23 ppm mixture of ferrous and ferric iron to a total of 
1.9 ppm. 
Heavy Metals - The detection level for total heavy metals is 
0.3 ppm. The data for the individual metals are self-explanatory. 
Particulates - The limits for injectables are less than 50/ml for 
particles larger than 10 u and less than 5/ml for particles 
larger than 25 u. A 0.2 u final filter will easily meet this 
requirement. 
Pyrogens - The Limulus Amebocyte Lysate Test is sensitive to 
0.25 ug/ml, which the test manufacturer claims is "several fold 
more sensitive than the rabbit test". The anion bed in OH form 
reduced a 10 ug/ml solution of E. coli 0111 endotoxin to less 
than the detectable level of the LAL test kit obtained from M.A. 
Bioproducts, Inc. 
Bacteria - Sterility - The USP Purified Water specifications 
require less than 2.2 Total Coliform/100 ml. The Sterile Water 
for Injection specification requires sterility when added to 
nutrient broth. The iodinated resin bed has shown the capability 
to meet these requirements. 
Oxidizable Substances - This test is an attempt at a simple test 
for organic materials, however it will respond to a wide variety 
of materials from ferrous iron to glucose. No direct attempt was 
made to challenge this requirement. 
- - 19 
Total Solids - This limit is irrelevant due to the levels of 
dissolved solids in the IV solution. 
Potassium - Sodium - Lactate - These are the tolerances for the 
final IV solutions. The cation bed was challenged with Na and K 
just to demonstrate the ion exchange capability. There is no 
conceivable way lactate ion could be in the raw water. 
6.2 Cartridge Design and Manufacture. 
The basic cartridge concept as shown in Figure 6-1 consists of an 
iodination section, interface section, and sorbent bed section. 
The contaminant challenge tests previously described, showed that 
a 4 cc bed of each type of sorbent would adequately protect one 
liter of water. Although it is not likely that any purifier 
would be exposed to the levels as high as the challenges, a 
margin of safety was desired in addition to the capability of use 
for more than one liter. These factors as well as the pressure 
drop exhibited by the small mesh size resins led to the adoption 
of larger beds. Experiments with various prototype 
configurations led to the adoption of a bed diameter of 
approximately 2 cm providing 6 cc of each resin. 
One of the primary criteria for the selection of a material for 
the cartridge was compatibility with the iodinated resin. 
Experience showed that polypropylene is the mose desireable 
material, other than fluorocarbons, from a standpoint of 
stability, easy machinability, and cost. Polypropylene cannot be 
glued, however heat bonding techniques have been developed to 
provide strong and reliable joints. The ready availability of a 
disposable polypropylene syringes has proven to be a. convenient 
source of materials for cartridge construction. The materials 
are known to be FDA approved, and the availability of syringes 
with luer lock fittings make them ideal housing materials. 
A schematic of the iodinated resin cartridge is shown in Figure 
6-2. This cartridge is sealed by membranes at each end to 
prevent the loss of iodine during storage, and more importantly 
when the entire purifier assembly is autoclaved. An iodine 
cartridge is assembled by cutting a 20 cc syringe to the 
appropriate length, and forming a membrane at the end by placing 
a drop of molten polypropylene over the hole and forming with an 
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RESIN RETAINER 
f 
f 
(3 I 
1 
MEMBRANE I 
BOTH ENDS 
FIGURE 6-2, 
IODINATED RESIN CARTRIDGE 
.UER LOCK F I TTI  NG 
BOTH ENDS 
- 2 1  - 
aluminum mandrel. A resin retainer, made by machining rod stock 
and heat fusing 100 mesh polypropylene screen, is inserted to 
provide space for the membrane penetrating needle above the 
membrane. 
References 2 and 3 ,  is then added, and another retainer pressed in 
place to compact the resin bed. The end of the cartridge, made 
from another 20 cc syringe with a membrane added, is then heat 
sealed to the body. This results with a hermetically sealed 
resin cartridge with luer lock fittings on each end. 
The iodinated resin, prepared and certified per 
The interface section contains the needle used to penetrate the 
membrane of the iodine cartridge and provide a secure flow path. 
Some of the approaches that were considered are shown in Figure 
6 - 3 .  
The first approach used a male luer lock attached to the needle. 
After the needle penetrated the membrane, the fitting was seated 
and twisted locking the fitting. It was found that a positive 
lock was difficult to achieve without being able to observe the 
relative positions of the fittings, and the seal between the 
cartridges could leak if twisted during handling. 
The second approach used a bellows to provide a perfect seal no 
matter how' the cartridge was handled after the membrane was 
punctured. The disadvantage of the bellows was a large dead 
volume which could introduce air bubbles during use. 
A third approach used a double ended needle mounted in a double 
ended luerlock fitting. Two membrances are punctured when the 
two sections are connected and twisted. This approach has the 
same disadvantages as the first. 
The adopted approach, shown in Figure 6-4, is similar to the 
bellows but uses surgical grade Silicone rubber tubing to connect 
the two cartridges. It is flexible enough to allow the membrane 
to be punctured, but there is essentially no dead volume 
surrounding the needle. This system has been tested up to 60 psi 
without failure, however it's tensile strength is limited and a 
nylon cord is used to prevent the two cartridges from being 
pulled apart due to mishandling. 
A schematic of the sorbent bed section is shown in Figure 6-5.  
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This is the final configuration and is somewhat different from 
that shown in Figure 6-1. During testing with units in the 
Figure 6-1 configuration, traces of iodine were detected in the 
bed effluent. A small bed of anion resin in the iodide form was 
added to remove all traces of iodine. In a test with a bacterial 
challenge using a mixed population of wild organisms in excess of 
10,00O/ml, the effluent was not completely disinfected, 
approximately 10 colonies per m l  were observed when plated on 
agar. The most logical explanation of this phenomenon is that 
the immediate removal of iodine from the stream did not allow 
sufficient contact time to deactivate any spores. The solution 
to this problem was the addition of a filter between the 
iodinated resin and the iodine removing resin. The filter 
selected was a depth type filter which is rated at a nominal 0.3 
microns. Although it is not an absolute filter like a membrane, 
challenges with bacteria containing water showed that the filter 
completely retains any viable organisms and spores. An absolute 
membrane filter was not selected because a membrane filter with 
an acceptable pressure drop would make the device unacceptably 
large. The filter retains all organisms larger than 0.3 microns, 
and is continuously exposed, after activation by puncturing the 
membrane, to iodine. Thus any spores that are trapped will be 
deactivated. 
The raw anion exchange resin is Dowex-1 purchased in the chloride 
form. The as received resin was found to contain a high level of 
viable bacteria and pyrogens. The resins were cleaned by boiling 
in pyrogen free water, and rinsing with ethyl alcohol. The resin 
was then cycled by converting it to the hydroxide form, rinsing, 
converting back to the chloride form, rinsing, and finally 
converting to the hydroxide form. This process yielded a resin 
that was pyrogen free. The washing and cycling process was all 
accomplished in a single day, and the final product autoclaved. 
A portion of this resin was converted to the iodide form for use 
as the iodine removal bed. 
The cation exchange resin is Dowex-SOW purchased in the hydrogen 
form. The as received resin was found to contain very few 
bacteria and was pyrogen free. This resin was also cleaned by 
boiling and an alcohol wash, followed by converting to the sodium 
form and back to the hydrogen form before autoclaving. This 
process also resulted in pyrogen free resin. Both resins were 
purchased as 50-100 mesh. 
i 
The activated charcoal was Sigma No 6-3014, 14-60 mesh. The as 
received charcoal was dry, and when rinsed showed a high specific 
conductance, indicating leachable inorganic salts, and contained 
pyrogens. An analysis of the water showed the salts to primarily 
be calcium and a trace of magnesium. The charcoal was washed 
with hydrochloric acid and rinsed until the specific conductance 
showed the acid was removed. The charcoal was then heated to 180 
degrees Centigrade in a nitrogen atmosphere to insure the 
destruction of pyrogens. Activated charcoal treated in this 
manner and stored dry remains pyrogen free. 
A cartridge was assembled by inserting a retaining screen which 
included a 3 micron fiberglass filter into the bottom of a 20cc 
syringe body. The filter r-etains charcoal dust which invariably 
forms due to handling. The activated charcoal was then added 
followed by the cation exchange resin, anion exchange resin, 
iodide form anion resin and a final resin retainer. The depth 
filter is a cylinder which provides for radial flow. One end of 
the cylinder is closed with a polypropylene disk by fusing the end 
with molten polypropylene. The other end is fused to a 
perforated disk which is fused to the body of the syringe, 
providing an absolute seal and requiring all water to flow from 
the inside radially through the filter. An end from a 20 ml 
syringe is then fused to the perforated disk, completing the 
assembly. A 15 gage needle is fitted to the filter end of the 
assembly which has a piece of silicone tubing stretched over its 
entire length. A polypropylene collar is then forced over the 
tubing at the base of the needle after a small amount of epoxy is 
applied. Although the epoxy does not bond to the polypropylene, 
it forms itself to all the irregularities in the joint and 
provides a positive seal. The other end of the silicone tube is 
installed in the end of the iodine cartridge in the same manner 
and the nylon cord attached to holes in the luer lock collars. 
The entire filling and assembly described above is accomplished 
in a single day, and the completed cartridge autoclaved. 
The assembled beds are then inserted in sleeves made from 30 ml 
syringe barrels and fused at the ends. The retaining ring, a 
section of syringe barrel is then inserted and tacked in several 
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places. This ring prevents the inadvertent puncturing of the 
inner membrane. As long as this ring is tacked in place, it is 
impossible to activate the bed and the internal integrity is 
assured. The final configuration is shown in Figure 6-6. 
6.3 Purifier Challenges 
The three types of contaminants which could conceivably be 
present in the potable water as it is supplied to the purifier 
are corrosion products from the water system, bacteria which may 
be present on the surface of the water dispenser port, and 
pyrogens on the surface of the dispenser port if bacteria 
are present. The purifier was tested with these contaminants in 
the feed water individually and in combinations. 
6.3.1 Metals Challenge 
Table 6-4 summarizes the results of challenges to a complete unit 
with the three metals representing the major constituents of 
stainless steel; iron, nickel, and chromium. The first set of 
data represent the third and seventh liters of an eight liter 
challenge. The first liter contained pyrogens, the second 
bacteria, the third the metals as listed, the fourth and fifth 
bacteria, and the sixth bacteria but on the following day. The 
seventh, tested two days later, contained metals. The levels of 
metals in the feeds were intended to be approximately ten times 
the USP limits. The USP limit for iron is 2 ppm, while nickel 
and chromium fall under the general requirement for heavy metals 
which is 0.3 ppm (total heavy metals). The data indicates that 
the bed adequately removes all three metals however the chromium 
limit was reached after the second liter. A sample of the first 
100 mls of the eighth liter showed no trace of any of the metals, 
demonstrating that the metals are irreversibly trapped, and 
metals removed from a short exposure to contaminated water will 
not be eluted in a later use. 
The data from 12-18 were only taken on the last 100 ml of a 
metals challenge, to obtain a worst case data point. It is 
evident that some breakthrough is occuring at the end of the 
first liter with these feed concentrations. 
The composition of 300 series stainless steels is essentially 71% 
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TABLE 6-4. CORROSION METALS DATA 
Test Day 
n 
12-4 I 
12-4 ! 
12-4 I 
12-4 I 
I 
I 
I 
I 
I 
I 
a, 
12-4 ~ 
12-5 
12-7 
12-7 2 
v, 
12-18 I 
I 
I 
I 
I 
I 
I 
I 
I 
Y 
Liter No. 
1 
2 
3 
4 
5 
6 
7 
8" 
1 
2 
3** 
Feed Concentration, 
PPm 
Fe Ni Cr 
0 0 0 
0 0 0 
15.3 3.3 1.8 
0 0 0 
0 0 0 
0 0 0 
16.8 3.2 1.2 
0 0 0 
0 0 0 
0 0 0 
16.8 3.2 1.2 
Effluent Concentration 
Fe Ni Cr 
PPm 
- - - 
0.8 <0.05 0.29 
<0.01. <0.05 <0.05 
- - - 
<0.01 0.2 0.11 
0.17 <0.05 n 2-5 I 1 5.7 2.9 2.1 0.1 
U 2 5.7 2.9 2.1 0.14 0.09 -0.07 
a, 
r 
v) 
L 
LL 
<0.05 0.29 
0.13 0.4 
USP limits 2.0 0.3 0.3 
m 
a, 4*** 5.7 2.9 2.1 0.35 
3 5.7 2.9 2.1 0.3 
U 
Skylab Corrosion 
Data 0.08 <0.05 0.002 
I * Data from first 100 ml 
I 
I **  Data from last 100 ml 
*** Data from first 500 ml 
iron, 11% nickel, and 18% chromium. The feed concentrations were 
adjusted to this ratio, maintaining the 10 times USP limit for 
nickel and chromium. Three successive liters were fed to a fresh 
polisher assembly on 2-5. This bed contains the iodine removing 
section, which reduced the size of the otherbeds slightly, 
however it demonstrates that the unit is effective for 3 liters 
of water with metals at these levels. 
During the preparation of this report, some long sought after 
data from the Skylab program was located. The Skylab was the 
first known system in which iodinated water was to be stored in 
stainless steel tanks for an extended period of time. The 
highest iron level encountered after 1 month in 304 SS was 0.08 
ppm, less than 0.05 ppm nickel in 321 SS after 4 months, and 
0.002 ppm chromium in 321 SS after 4 months. The data show the 
metal challenge protocol to be many orders of magnitude more 
severe than is expected to be encountered. 
6.3.2 Microbial Challenges 
Table 6-5 summarizes the microbial challenges of assembled units. 
In all cases the source of bacteria was the natural population 
which exists in URC's deionized water system. Although the 
identity of organisms has not been established, it is known that 
the predominant species are pseudonomads. These organisms are 
conditioned to live in very low nutrient environment, and should 
be quite representative of those encountered as contaminants in a 
space craft's water system. Challenges were performed either as 
pure deionized water, or in conjunction with metals or in some 
cases pyrogen challenges. Challenges with enteroviruses were 
performed when convenient during a parallel program, NAS9-15854, 
in which the Microbial Check Valve resin was being challenged 
with enteroviruses. 
The first two liters fed to the unit tested on 12-4 were pyrogen 
challenges in sterile water, the third liter was a metals 
challenge made from deionized water. Liters four and five, and 
liter six which was fed the next day were all deionized water 
containing large numbers of organisms. The aerobic plate counts 
of the effluents show that a few viable organisms were getting 
through. The values shown are from duplicate plates. As 
previously discussed it is assumed that these are spores which 
. .  
T e s t  D a y  L i t e r  N o .  
12-4 1 
2 
3 
4 
5 
6 
I 
TABLE 6-5. MICROBIAL CHALLENGE DATA 
12-5 
1-7 
2-5 
2-21 
1 
1 
2 
3 
4** 
* A e r o b i c  P l a t e  C o u n t  
** D a t a  from first  500  ml 
A P C * F e e d  APC *Out  
0 
0 
6 x l o 5  
6 x l o 5  
6 x l o 5  
6 x l o 5  
4 x io4 
3 x 103 
3 x i o 3  
3 x i o 3  
3 x i o 3  
3 . 1  1 0 5  
3 . 1  1 0 5  
3.1 1 0 5  
3.1 x 1 0 5  
3.1 x 1 0 5  
3.1 1 0 5  
R e m a r k s  
Contained meta ls  
Contained metals 
I1 11 11 
I1 I1 I1 
11 It  11 
Incorporates F i l t e r  
11 11 11 
I1 11 I1 
I1 I1 
11 11 
It I1 
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are not deactivated due to the short contact time with the 
iodine. The outlet plate counts from the test on 12-5 with the 
same bed shows that even if the spores do get past the iodine, 
they do not germinate overnight in the lower portions of the 
unit, and that a bed may be reused without contamination. The 
test on a new unit on 1-7 showed complete deactivation. The 
tests run on 2-5 was an extended metals challenge with a 4 liter 
batch of challenge solution. The plate counts including the feed 
showed some viable organisms getting through. The lower feed 
concentration of bacteria is probably due to the presence of the 
heavy metals during the time required to conduct the entire test. 
The unit tested on 2-21 contained the 0.3 micron filter. As 
previously mentioned, this filter was challenged alone with 
bacteria containing deionized water and proved to remove them 
all. This exhaustive test shows the ability of the filter 
containing purifier to completely remove bacteria from a large 
amount of contaminated water. The one positive plate from liter 
two is most likely a sampling error. 
The unit used for the 1-7 bacteria challenge was challenged three 
days later with Reovirus. A liter containing a TCD50 (50 percent 
Tissue culture Infectious Dose) of 19,000 Reovirus/ml was passed 
through the cartridge. The effluent contained a TCD50 of less 
than 0.1, indicating instantaneous complete inactivation of this 
virus. A plate count also showed no bacteria in the effluent. A 
fresh cartridge was challenged with one liter of Type 1 Polio 
virus. The feed contained a TCD50 of 17,800. The effluent 
contained a TCD50 of 100. Disinfection was not complete. Polio 
virus is one of the most resistant viruses to chemical 
disinfection. Results with the microbial check valve show 
complete deactivation within 15 minutes after iodine contact. 
Other published data, Reference 7 ,  show Polio to be very resistant 
to chlorine as well. 
6.3.3 Pyrogens (See Appendix 1 for a short description of 
Pyrogens and their source) 
At the beginning of this development program, the current edition 
of the USP was the 20th. This edition required that all 
injectables meet the Pyrogen Test <151> which involves injecting 
rabbits with the solutions in question and observing their 
temperatures. The 20th edition also included the Endotoxin Test 
- 3 3  - 
<85> which uses Limulus Amebocyte Lysate (LAL) to detect 
endotoxins (pyrogens). At that time it was recognized that the 
LAL test was more sensitive than the rabbit test, and it was used 
to evaluate the ability of the water purifier to remove pyrogens 
from the water stream. One Reference, ( 4 ) ,  indicated that the 
LAL test was from 3 to 300 times more sensitive than the rabbit 
test, and the manufacturer of a LAL test kit claimed, "several 
times more sensitive than the average rabbit pyrogen test". It's 
guaranteed sensitivity was 0.25 ng/ml. Based on this information, 
the ion exchange resins were challenged with 1 liter of water 
containing 10 ng/ml of pure endotoxin, and when tested with the 
LAL kit showed negative response. Thus it was assumed that the 
water polisher could easily purify pyrogen contaminated water to 
a level that would pass the rabbit test. The USP is continuously 
revised, and supplement 4a to the 20th edition replaced the 
Pyrogen Test <151> with the Endotoxin Test <85> as the pyrogen 
requirement for Water for Injection. It is also included in the 
21st edition. In addition, it specified a limit for endotoxins 
of 0.25 EU/ml. The endotoxin unit, EU, is defined as an 
endotoxin which has the same response as an FDA standard 
endotoxin. Another requirement that was established was that an 
acceptable endotoxin standard must have a minimum activity of 5 EU/ng. 
If we assume that the endotoxin used in the previously described 
purifier challenge had an activity of 5 EU/ng, and the detection 
limit was 0.25 ng/ml, then the detection level was 0.25 ng/ml x 5 
EU/ng = 1.25 EU/ml. This is five times the new level of 0.25 EU/ml. 
An alternative source of LAL was found together with a source of 
Endotoxin standards with a certified EU activity. This LAL was 
found to give a reliable positive test of an endotoxin level of 
0.125 EU/ml. 
. Challenges of the water purified were made with water containing 
2.5 EU/ml (10 times USP requirement). Four purifiers were 
challenged, and none was able to produce an effluent with less 
than 0.25 EU/ml. 
The conclusion is that the purifier is capable of producing water 
which will meet the requirements of USP 20, as was the original 
intent of the program, but the new limits are not obtainable with 
the original technology. 
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A different approach must be used to meet the new endotoxin 
limit. Hyperfiltration, References 5 , 6  has been used to 
physically remove pyrogens from water. The removal is based on 
physical filtration by a matrix with pores smaller than the 
endotoxin molecule. The above listed references both report 
complete removal of endotoxins with membranes with a molecular 
weight cutoff of 10,000. The small pore size of the membranes 
produce a very large pressure drop, requiring high surface areas 
for reasonable flow rates. The solution to this is the hollow 
fiber membrane module as shown in Figure 6-7. A large number of 
tubes made from the membrane material are mounted in a housing. 
Water containing endotoxins is forced through the inside of the 
tubes and passes through the membrane wall leaving the endotoxin 
molecules inside the tube. 
A hollow fiber membrane module was purchased from Amicon (Model 
H l P 1 0 - 2 0 ) .  The module was shipped containing a preservative of 
0 . 2 %  sodium azide and glycerin. It was found to contain pyrogens 
as well. The manufacturer recommends that the unit not be 
repeatedly autoclaved since the pore size of the membrane 
increases each time it is autoclaved. 
Three liters of water were passed through the module to remove 
the glycerin/azide. The specific conductance of the first water 
was 140 umho/cm, but was less than 5 after the 3 liters. A liter 
of pyrogen free water was then fed through the module followed by 
a liter containing 2 5  EU/ml of endotoxins (100 times the USP 
limit). The effluent from the 2 5  EU/ml water showed less than 
0.1 EU/ml. In an effort to evaluate the effect of autoclaving, 
the module was autoclaved for 15 minutes and challenged with a 
liter containing 2 5  EU/ml. No pyrogens were detected in the 
effluent. The module was autoclaved two more times and 
challenged with 2 5  EU/ml water. N o  pyrogens were detected in 
either effluent. After the fourth autoclaving, the effluent 
showed an inconclusive positive test, estimated at 0.08 EU/ml. 
After the fifth autoclaving, the effluent showed a positive test, 
greater than 0 . 1 2 5  EU/ml. The above series of tests shows that 
the unit may be safely autoclaved at least once, and is a viable 
solution to the pyrogen removal problem. The module also 
provides another positive barrier to microbial contamination. It 
is also sold as a device which can be used to concentrate virus, 
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although this has not been investigated. 
A schematic of a water purifier which will meet all the 
requirements of USP 21 is shown in Figure 6-8. A hollow fiber 
module is attached to the original purifier Such that the 
effluent from the cartridge is fed to the inner tubes of the 
hollow fiber module. The effluent from the module is then 
available for reconstituting concentrates as before. The entire 
assembly can be autoclaved as a unit after manufacture, thus 
guaranteeing sterility before use. 
- 3 7  - 
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7.0 ADMINISTRATION DEVICES 
The major challenge in the administration device is the 
development of a system that is capable of producing a steady, 
verifiable and controllable flow under conditions of micro 
quality. Two methods of expulson of the fluids were considered, 
mechanical and pneumatic. 
The most obvious form of mechanical expulsion is a pump. A wide 
variety of variable speed positive displacement pumps are readily 
available. These devices are widely used in hospitals to ensure 
stable infusion especially in long term applications. This 
approach was not selected due to its high stored weight and 
volume, and more importantly its requirement for either a vehicle 
interface for power or battery charger, or the necessity of 
providing a supply of fresh batteries for each mission. 
Another form of mechanical expulsion is a spring loaded bag 
squeezing device. An ideal device is one that uses a spring that 
has a constant force over a long distance of travel. This 
provides a constant delivery pressure and allows the use of very 
simple flow controllers. The IV-Stat, shown in Figure 7-1 is 
ideally suited for this application. It is designed to provide 
continuous and steady pressure throughout the expulsion of a one 
liter IV bag. The device is quite heavy, however, and very 
difficult to operate. The locking and release mechanism is 
unpredictable (and relies on gravity), and could be dangerous to 
the operator if accidentally released. 
The ideal pneumatic system would provide a constant gas pressure. 
One’approach would be to use vehicle nitrogen through a 
regulator, but it is not desireable to have any vehicle 
interfaces. Another approach would be an independent compressed 
source of gas and regulator, but that approach would be heavy, 
and require extensive ground support before launch and extensive 
testing before flight certification. Chemical generation of C 0 2  
through the reaction of sodium carbonate and acetic or citric 
acid could provide an easily stored and instantly activated 
pressure source, however flight certification would be expensive, 
and would not provide a constant pressure supply. Other chemical 
propellants such as flurocarbons and hydrocarbon mixtures which 
can be selected to provide a constant pressure would be useful, 
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Figure 7-1 ORIGINAL PAGE 3 
OF POOR QUALITY 
LV, STAT 
without adjustment, until it is completely empty. It provides the same 
constant pressure whether it is full or partially infused. The spring produces a 
pressure of 100 mm Hg. 
QUICK AND CONVENIENT APPLICATION 
The I.V. STAT can easily be put in service within 10 seconds. Constant pressure 
operation eliminates need for extra staff to hold or hang bag overhead. 
The lightweight unit can be placed next to patient on stretcher or bed. Reduces 
monitoring work. Also handy for use by ambulatory patients. 
HERES HOW IT WORKS 
- 
I.V. STAT SPECIAL FEATURES ._ 
Supplies a constant, safe pressure for blood, plasma or 
Maintains uniform flow rate, as originally set, throughout infusion. 
Eliminates monitoring during infusion since removing fluid 
from the container does not alter the output pressure. 
Operates without necessity of being elevated above the patient. 
I.V. solutions. 
Provides complete portability and eliminates need for I.V. 
stand, but may be hung from one when convenient. May 
be placed on any convenient surface near patient. 
0 Works with any standard I.V. tube set. 
0 Activates rapidly - in operation within 10 seconds. 
0 Sterilizes by steam autoclaving, gas or dry heat and is 
0 Simple to operate - instructions on unit. 
0 Non-breakable metal components for maintenance free, 
0 Thoroughly engineered and attractively designed. 
0 Does not require electrical wiring or batteries. 
washable in hot water detergent. 
long life. 
e iiu "wiiiu-up" UI "puriip up." iiu "piuy-iii.'* 
SPECiFiCATiONS 
output Pressure 100 mrn Hg. 100 mm Hg. 
Capacity 600 cc 1,000 cc 
Overall Dimensions: 
Height 9 crn (3.5) 9 crn (3.5) 
Width 15 crn ( 6 )  15 cm ( 6 )  
Length 39 crn (15.5) 46 crn (1 8") 
Weight 1 Kg (2.2 Ibs) 1.05 Kg (2.3 Ibs) 
Activating Force 9 Kg x 22 cm 
and Stroke: (20 Ibs x 8.7) 
Construction: 
All metal, satin anodized aluminum and stainless steel with silicone rubber pad. 
MODEL 250 MODEL 250-X 
9 Kg x 28 crn 
(20 Ibs x 11.2") 
1. ACTIVATE - Retract handle 
to activate and lock open. 
2. LOAD - Droo I.V. baa 
on pad to load. 
e(hr F a  
3. RELEASE - Retract 
handle to unlock and 
release to pressurize bag. 
Box 961, La Jolla, California 92038 
(714) 459-4577 
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Clinical reference: 
BIOMATERIALS. MEDICAL 
DEVICES, AND 
ARTIFICIAL ORGANS 
Z(1). 41/46 (1974) 
but would not be allowed in the spacecraft. 
A hand pump is the lightest, most flexible, most reliable solution 
to the problem. A commercially available device was found that 
is designed to pressurize blood bags. The Fenwal Number 4R 4403 
Pressure Infusor is ideally suited to the needs at hand. It 
consists of a cuff which will hold a 1 liter bag connected to a 
bladder. The bladder is inflated with a bulb, and the pressure 
indicated on a gage, see Figure 7-2. This system does not 
provide constant pressure, but will satisfactorily function with 
the flow system described below. 
A flow regulator suitable for use with a constant pressure system 
is shown in Figure 7-3. A tapered flow path is formed between 
the flattened walls of a piece of plastic tubing. This can be 
used to form a variable size precalibrated orifice. By placing a 
clamp at calibrated positions along the tubing, it is compressed 
to the flats, but the orifice remains open. The tube is open 
above and below the clamp, thus producing a variable and 
predictable orifice. A similar device is shown in Figure 7-4. 
This device uses a tapering spiral groove, the orifice point of 
which can be adjusted by moving a rubber retainer to a 
precalibrated point. This device was shown to function reliably 
with the IV Stat pressurization device. 
A flow controller that is relatively insensitive to pressure is 
shown in Figure 7-5. This device operates on a pressure feedback 
principle, and has been found to maintain a constant flow rate 
through a relatively wide range of upstream pressures. When 
combined with the Fenwall Pressure Infuser, the resulting system 
is a simple, reliable, and light infusion system which has no 
expendables and requires no interface with the vehicle. The 
Umpqua Research modified pressure gage on the infuser is marked 
with a red zone which defines the pressure range over which the 
regulator maintains constant flow. Flow characteristics are 
given in Table 7-1. 
Conventional infusion systems use a drip chamber to verify flow 
and give some indication of flow rate. A gravity independent 
drip chamber was developed which will give the same information, 
see Figure 7-6. As liquid is fed to the tube contained in the 
Transparent chamber, a drop forms on the end. It continues to 
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Figure  7-5 
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The unique, constant-flow regulator 
in an i.v. set for single use 
schematic diagram: 
A Silicone rubber sheet 
separates the two halves of a 3 x  
thin. plastic sandwich. Internal. ir,let Plug 
two circular membranes are I I 
formed which are completely 
tight. 
A tap for the drip rate is located 
at the front of the regulator. 
A filter (1 5 micron) is 
incorporated in the back of the 
regulator. 
Flow-rate and stabilisation: The 
tap is avariable resistance. It serves 
The resistance in the groove of the 
tap causes a difference in pressure, 
depending on the flow rate. 
1 - - ^ -  t - -*:-- .L-A-:---*-  
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This is thesignal' in afeed back 
system. It causes a displacement of 
the lower membrane, which is 
opposite the outlet orifice. 
The displacement of the lower 
membrane causes a steeply 
.,increasing resistance at the outlet 
orifice. 
This reduces the flow, the signal, 
and finally the displacement of the 
lower membrane. The circle is 
closed. 
During the normal operation, the 
membrane is trapped in a position 
which is very close to the orifice. Any 
initial variation of the drip rate is 
followed by an immediate change in 
resistance, which counteracts the 
initial variation of the flow. 
silicone rubber sheet 
dimensions: 28 x 48 x 6 mm 
note: membranes are 
completely tight 
The infusion via one or more inlets 
can be selected. Normally. they are 
interconnected 
-If a red indicator plug IS inserted the 
tip of the plug acts on the dry side of 
the upper membrane 
The membrane is pushed inwards 
and it obstructs the corresponding 
inlet. 
When the liquid level drops below 
the container. the pressure behind 
the upper membrane decreases 
rapidly.%he membrane returns to its 
natural position, thereby clcsing the 
filter inlet and the infi isinn stone 
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TABLE 7-1. 
FLOW CHARACTERISTICS 
DELIVERY NEEDLE GAGE 
25 
2 1  
20 
16 
14 
MAXIMUM FLOW, cc/min 
10 
40  
4 2  
67 
67 
i 
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grow until it is large enough to touch the hydrophilic material, 
which wicks the liquid by capillary action into itself and 
conducts it to the exit tube. In micro gravity the drop could be 
quite large if left undisturbed, but the actual device was 
designed to operate in any orientation under normal gravity, and 
the spacing between the end of the tube and wick, and consequently 
the drop size, is limited. This gives a device which will operate 
in any orientation and is insensitive to being bumped or moved 
when operating. 
The system used to quantitatively measure the flow rate is shown 
in Figure 7-7. A small bubble of air is introduced in to the 
flow path. This is accomplished with a syringe through a 
hydrophobic membrane filter which prevents the liquid from 
flowing out, eliminating the need for a check valve, and 
preventing bacteria from entering the system (maximum pore size 
0.2 microns). The bubble is swept along the tube and as it 
passes through the calibrated section, an observation is made of 
the distance it travels in 30 seconds. The calibrations on the 
tube indicate the flow rate in cc per hour. Before the bubble 
reaches the patient it is removed in the gas separator. This 
separator consists of a 0.2 micron hydrophilic membrane which 
will not allow air (or bacteria) to pass through it once it is 
completely wet. The tapered upstream section contains a 
hydrophobic membrane vented to the outside. The shape of this 
chamber insures that any air is swept along the hydrophilic 
membrane until it reaches the hydrophobic, where it readily 
passes through. This separator has been tested in all 
orientations and flow rates and has performed flawlessly. 
A schematic of the administration system is shown in Figure 7-8. 
The fill tube ending in a needle to penetrate a concentrate pouch 
is connected to an upper corner of the bag. The outlet from the 
bag, also at the top is directly connected to the flow regulator. 
The outlet from the regulator has a tee which contains the 
hydrophobic air injection filter. The other leg of the tee 
connects to the calibrated tube which terminates at the drip 
chamber. The outlet from the drip chamber goes to the air 
separator. The outlet at the separator goes to a medication port 
tee which is terminated with a short tube and a male luer lock. 
A small purge bag is installed at the end with a female luer 
lock. Another medication port is provided at an upper corner of 
the bag. 
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8.0 SYSTEM DESCRIPTION AND OPERATION. 
8.1 System Description 
The system is composed of a fill hose, purification cartridge, 
concentrate pouch, and administration set. These items are shown 
in Figure 8-1. The only item that has not been described in 
detail is the fill hose. This hose is a length of tygon tubing 
with a female luer lock fitting in which an 18 gage needle is 
mounted. This needle is used to penetrate the membrane on the 
fill end of the purifier. The other end of the fill hose is to 
be fitted with an adapter compatible with the shuttle potable 
water dispenser. The fill hose is packaged separately in a 
non-sterile envelope. The water polishers and concentrate pouchs 
are indivdually packaged in foil envelopes. The administration sets 
are packaged in sterile transparent envelopes which contain purge 
bags for the water polisher, and the administration set. It also 
contains an illustrated instruction sheet, Figure 8-2 .  This 
envelope is also wrapped in a foil package. The pressure infuser 
is packaged in a separate foil envelope. 
8.2 Operation 
The first step in the use of the system is to remove the pressure 
infuser and an administration set from the foil envelopes. The 
administration set is then removed from the plastic envelope and 
the large purge bag set aside for later use. The IV bag is 
slipped under the mesh covering of the pressure cuff, and the 
flow regulator turned off by moving the handle to the bag surface 
and the clamp on the fill line opened. The pressure cuff is then 
inflated by closing the knurled knob on the squeeze bulb and 
pumping until positive pressure appears on the gage. This 
procedure removes all the air from the bag through the fill line. 
When positive pressure is observed, the clamp on the fill line is 
closed, and the pressure released in the cuff by unscrewing the 
knurled knob on the bulb. 
Note: All fittings have been selected so that there is only one 
way to connect the components. 
The water polisher is removed from it's foil envelope and 
activated by removing the snap ring from the center of its body. 
p: 
0 
5\ 3
c3 
W 
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NAS 9- 16337 OPERATING INSTRUCTIONS 
1. PLACE RESERVOIR BAG I N  CUFF AND 
OPEN F I L L  CLAMP. 
2. INFLATE CUFF USING SQUEEZE BULB 
UNTIL GAGE SHOWS POSITIVE 
PRESSURE (REMOVING A I R  F i l l  
FROM RESERVOIR BAG). 
3. CLOSE F I L L  CLAMP AN0 OPEN 
VENT OK SQUEEZE BULB TO 
DEFLATE CUFF. 
F l o w  
R e g u l a t o r  
4. REMOVE INJECTION WATER POLISHER FRon FOIL PACKET. 
5. REMOVE SNAP RING FROM WATER POLISHER AND PUSH 
TOGETHER TO PUNCTURE INNER MEMBRANE. 
6. CONNECT HOSE FROM COLD WATER DISPENSER TO 
INJECTION WATER POLISHER. 
7. CONNECT WATER POLISHER TO PURGE BA6 
AND FLUSH POLISHER WITH APPROX. 
6 OUNCES OF UATER. (TURN OFF 
Yater DISPENSER WATER. ) 
DESIRED CONCENTRATE POUCH TO POLISHER. 
CENTRATE POUCH, OPEN F I L L  C W  To Cold - 
AND TURN ON DISPENSER WATER. 
Snap 
P u r g e  Bag 
8. DISCONNECT PURGE BAG AND CONNECT 
Pouch 9. CONNECT RESERVOIR BAG TO CON- c-a, > F i l l  h t c r  D i s p e n s e r  
Hose 
IC!. F I L L  RESERVOIR BAG l l W U G H  POLISHER AND CONCENTRATE POUCH WITH 32 OUNCES OF WATER. 
(TURN OFF DISPENSER MATER AND RWDVE POLISHER.) 
11. WEAD RESERVOIR BAG TO MIX INGREDIENTS AND REPLACE IN CUFF IF BAG WM REMOVED. 
12. INFLATE CUFF TO TOP OF RED ZONE a GAGE. 
13. OPEN FLOW REGULATOR ABOUT MLFUAY AUD PURGE AIR I N  LINES INTO SHALL PURGE BAG. 
14. CLOSE FLOU REGULATOR AN0 REllDVE S M L L  PURGE BAG. 
15. CONNECT END OF TUBE TO NEEDLE NtD INSERT I N  PATIENT. 
16. OPEN FLOW REGULATOR ABOUT ONE THIRD. bND WNITOR FLOU BY OBSERVING DISTANCE BUBBLE 
PRODUCED BY AIR SYRINGE MOVES I N  30 SECONDS. (CC PER HOUR) 
17. ADJUST FLOW AS DESIRED. (OBSERVE IN-LINE DRIP CHAMBER TO VERIFY FLOW) 
18. M I N T A I N  PRESSURE CUFF YITHIN RED ZONE ON 6AGE TO ENSURE CONSISTENT FLOU. 
19. REFILL AIR SYRINGE BY REMOVING neOn FILTER. 
UIpPuA RESEARCH C W A N Y  
MYRTLE CREEK. OR 97457 
P.D.BOX 791 626 N.E. DIVISION 
FIGURE 8-2, 
OPERATING INSTRUCTIONS 
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If this snap ring is not securely tacked to both sections of the 
unit it should be discarded and another unit selected. When the 
snap ring is removed, the two ends are pushed together to 
puncture the inner membrane and activate the unit. The relative 
position of the two sections after activation is not siginificant. 
The Fill Hose is removed from its packet and connected to the 
potable water dispenser. The needle end is inserted into the 
fill end of the polisher to puncture the membrane and then locked 
by turning clockwise. The large purge bag obtained from the 
administration set package is installed at the outlet end after 
removing the protection cap, inserting the needle in the bag 
fitting and locking by turning clockwise. This end of the 
purifier must remain sterile and all connections from this point 
on must be made using aseptic technique. Air is purged from 
the polisher by flowing approximately six ounces of water into 
the purge bag. The bag is then removed prior to reconstituting a 
solution. 
A concentrate pouch is selected and removed from its foil 
needle to puncture the membrane and locking by twisting 
clockwise. The IV bag in the Pressurization cuff is then 
connected to the other end of the concentrate pouch in the same 
manner. The fittings are arranged such that an IV bag cannot be 
filled without going through a concentrate pouch. The solution 
is then prepared by delivering 3 2  ounces of water from the 
potable water dispenser. After filling, the clamp is closed on 
the bag and it is disconnected from the concentrate pouch. The 
pouch is discarded and the cap replaced on the needle end of the 
polisher. It may be reused if care was taken not to touch the 
needle. The fill end of the polisher should be disconnected and 
capped, however this end need not be maintained sterile. 
envelope. one end is connected to t h e  p u r i f i e r  by * - - ' - -  u3111y L I I C  
The IV solution is now ready for use. The pressure cuff is 
equipped with a simple harness which may be placed over the 
patients head and a strap which goes around the waist to maintain 
it in a convenient position on the chest. The bulb is then 
pumped until the pressure gage is reading at the top of the red 
zone. As long as the pressure is kept in the red zone, the flow 
regulator will maintain a constant preset flow rate. Once 
pressurized the flow regulator is opened until flow commences and 
- 5 4  - 
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reaches the small purge bag at the end of the hose. The bag is 
then removed, a needle attached and installed in the patient. 
The regulator is then opened and flow observed in the drip 
chamber. Quantitative flow measurements are made by installing 
the small syringe in the filter on the top of the IV bag and 
injecting a small air bubble into the line. By observing the 
distance the bubble travels through the calibrated tube over 30 
seconds, the numbers on the tube indicate the flow rate in cc/ 
hour. 
Periodic observations of the drip chamber will verify that the 
system is operating correctly. The pressure gage should always 
read in the red zone to guarantee consistent flow rates. 
Medication may be injected directly into the IV bag for long term 
administration, or directly into the patient by closing the clamp 
immediately above the lower port and injecting. 
If a second liter of solution is required, a fresh administration 
set must be prepared from a concentrate pouch, and connected to 
the installed needle. 
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fUBJ: Pyrogen (Endotoxin) Free Water For I n j e c t i o n  - Space Stat ion 
A pyrogen i s  any substance t h a t  produces a f e b r i l e  response when i n j e c t e d  i n  man o r  
o ther  mammals. Endotoxins are high-molecular-weight complexes associated w i th  the  
ou te r  membrane o f  gram-negative bac te r ia  ( G N B ) ,  and are the most s i g n i f i c a n t  pyrogen 
for the pharmaceutical i ndus t r y  (Attachment 1). A1 though i n t i m a t e l y  associated w i th  
the b a c t e r i a l  c e l l  membrane, these tox ins a re  constant ly shed i n t o  the environment 
o f  the bacterium, much l i k e  the d a i l y  shedding o f  s u p e r f i c i a l  l aye rs  of human skin.  
When the bacterium undergoes auto lys is ,  a l l  endotoxin i s  released from the c e l l .  
U I I ~ U I  I I endotcxins contain 1 i p i d ,  carbohydrate, and prote in ,  but  h i g h l y  p u r i f i e d  
endotoxins do not contain p r o t e i n  and, therefore,  are re fer red t o  as l i popo lysac -  
char ides (LPS) t o  emphasize t h e i r  chemical nature. Endotoxins are heat-stable com- 
pounds t h a t  can survive ord inary steam s t e r i l i z a t i o n  cycles; however, they are 
i n a c t i v a t e d  by extended dry heat cycles, a lkal i f ie condit ions, a c i d i c  condit ions, and 
polymyxin B, under ce r ta in  condit ions. Although it was f i r s t  recognized t h a t  endo- 
t o x i n  causes fever, i n  more recent years endotoxin has been shown t o  have profound 
ef fects  on a broad spectrum o f  b i o l o g i c a l  a c t i v i t i e s .  
Recent invest igat ions have demonstrated t h a t  v i r t u a l l y  a l l  b i o l o g i c a l  a c t i v i t y  of 
endotoxin resides i n  the l i p i d  p o r t i o n  o f  t h e  molecule. Where-as one p o r t i o n  of 
endotoxin i s  responsible i n  l a r g e  p a r t  f o r  the ant igenic  i n d i v i d u a l i t y  of gram- 
negat ive bacter ia  and i s  thus responsible f o r  thousands o f  serotypes, another po r -  
t i o n ,  the core port ion, i s  remarkably uni form i n  many r a t h e r  d iverse groups of 
gram-negative bacter ia (GNB). Thus, endotoxin contr ibutes t o  the an t i gen ic  homo- 
gen i t y  and heterogenity o f  GNB. 
Endotoxins are ubiquitous and l i k e  bac te r ia  are found i n  a i r ,  water, and food. Due 
t o  t h e i r  ub iqu i ty ,  r e l a t i v e  heat s t a b i l i t y ,  and a b i l i t y  t o  cause profound phys io log-  
i c a l  changes when administered parentera l ly ,  t h e i r  detect ion and e l  im ina t i on  i s  of 
paramount concern t o  the manufacturer o f  parentera l  products. 
The problems associated w i th  u t i 1  i z i n g  Space Stat ion condensate f o r  rehydratable 
i n j e c t a b l e s  are numerous and i n  some instances q u i t e  formidable. That i s ,  if NASA 
intends t o  meet FDA regulat ions, a thorough study o f  the appl icable requirements i s  
essent ia l .  The FDA uses the standards f o r  "Water f o r  I n j e c t i o n "  as o u t l i n e d  i n  "The 
I f - - . . - :  e:,.# 
I 
I 
2 
for  i n j e c t i o n  i s  water p u r i f i e d  by 
requirements the water must pass 
water contains not more than 0.25 
United States Pharmacopeia (Attachment 2). Water 
d i s t i l l a t i o n  o r  by reverse osmosis. Anon9 other 
the  Bac te r ia l  Endotoxin l e s t  (Attachment i); the 
USP Endotoxin Un i t  per m i l l i l i t e r .  The Limulus Amebocyte Lysate (LAL) i s  t he  o f f i -  
c i a l  t e s t  for  pyrogens (endotoxins) according t o  Dr.  Terry Munson, FDA, FTS 87 443- 
7291. One may p e t i t i o n  
t h e  FDA t o  use the r a b b i t  t e s t  i n  l i e u  of the LAL. 
The “ r a b b i t  t e s t ”  i s  no longer required but i s  acceptable. 
I would recommend the use o f  the LAL t e s t  f o r  our purposes. It i s  not feas ib le  t o  
conduct the “ r a b b i t  t e s t ”  a t  JSC; it would requi re a contract  with an outs ide labo-  
ra tory .  F i n a l l y ,  I am not  p a r t i c u l a r l y  o p t i m i s t i c  about meeting FDA standards f o r  
i n j e c t a b l e  water by f o l l o w i n g  the current plan. This very important 
Smnediate and comprehensive review whi le we are i n  the e a r l y  planning 
issue needs an 
phase. 
-. 
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LAYERS 
COMPONENTS 
f 
Lipoprotein 
"Oantigen . 
ride c h a k  
Other O M  protein 
FIG- 6-.f 4. Oiagram of a gram-negative cell envelope. Components are listed on (he right. The trimers of matrix prolein of the Om are 
associated wifh lipoprotein and with LPS (of variable mlysaccharide length). and lipoprotein is covalently bound to' peptidoglycan. 
Diagram also illustrates some general properties of membranes (see Cytoplasmic Membrane). Phospholipid molecules are illustrated 
with a circle for the polar groups. and a l ine lor each fatty acid acfl moiety. 
. 
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